- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07638644
Comparison of Acupressure, Ibuprofen, and Chewing Gum for the Management of Post-Archwire Orthodontic Pain
Comparative Efficacy of Acupressure, Ibuprofen, and Chewing Gum in Managing Post-Archwire Orthodontic Pain: A Three-Arm Randomized Clinical Trial
The goal of this clinical trial is to find out which method works best to reduce pain after braces are adjusted for the first time (when the first archwire is placed). The study will compare three approaches: acupressure (applying pressure on a specific point on the hand), ibuprofen (a pain-relief medicine), and chewing sugar-free gum. It will also check how safe these methods are and whether patients need extra pain medicine.
The main questions the researchers want to answer are:
Which method reduces orthodontic pain the most after the first archwire is placed? Do patients need extra painkillers in any of the groups? Are there any problems with braces (such as loose brackets or wire issues) within the first week?
Researchers will compare the three groups to see which option gives the best pain relief during the first few days after braces are activated.
Participants will:
Be placed into one of three groups: acupressure, ibuprofen, or chewing gum Use their assigned method after their first orthodontic wire is placed Rate their pain at different time points using a simple pain scale (VAS) Report if they take any extra pain medicine Be checked for any brace-related problems for up to 7 days
This study may help improve comfort and pain management for patients starting orthodontic treatment.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Tipo di studio
Iscrizione (Stimato)
Fase
- Non applicabile
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Bambino
- Adulto
Accetta volontari sani
Descrizione
Inclusion Criteria:
- Age 15 to 35 years
- Complete permanent dentition
- Undergoing comprehensive fixed orthodontic treatment
- Scheduled for initial archwire placement
- Ability to comply with study procedures
- Written informed consent provided (or parental/guardian consent for participants younger than 18 years)
Exclusion Criteria:
- Pregnant or lactating
- Systemic disorders that may affect pain perception
- Periodontal disease
- Neurological abnormalities that may affect pain perception
- Known sensitivity to chewing gum
- Documented allergy to ibuprofen
- Use of adjunctive orthodontic appliances
- Use of analgesics, anti-inflammatory medications, or other medications that may affect pain perception within 24 hours before enrollment
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Separare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Acupressure Intervention
Participants in this arm will receive instructions on the use of acupressure for orthodontic pain management following placement of the initial archwire.
Verbal instructions and a standardized advice sheet will be provided.
Participants will be trained to apply steady, perpendicular pressure using the thumb of the opposite hand to the LI4 (Hegu) acupressure point for approximately 3 minutes.
The location of the LI4 point will be demonstrated and identified as the point on the dorsum of the hand between the first and second metacarpal bones, at the midpoint of the second metacarpal bone near its radial border.
Participants will be instructed to perform acupressure according to the standardized study protocol.
|
Participants in this arm will receive instructions on the use of acupressure for orthodontic pain management following placement of the initial archwire.
Verbal instructions and a standardized advice sheet will be provided.
Participants will be trained to apply steady, perpendicular pressure using the thumb of the opposite hand to the LI4 (Hegu) acupressure point for approximately 3 minutes.
The location of the LI4 point will be demonstrated and identified as the point on the dorsum of the hand between the first and second metacarpal bones, at the midpoint of the second metacarpal bone near its radial border.
Participants will be instructed to perform acupressure according to the standardized study protocol.
Altri nomi:
|
|
Comparatore attivo: Ibuprofen Intervention
In the ibuprofen group participants will be provided with a 400 mg oral dose post arch wire placement.
With a minimum gap of 8 hours between doses, remaining doses will be taken as per need for the relief of pain with the total daily dose not surpassing 1200 mg.
|
In the ibuprofen group participants will be provided with a 400 mg oral dose post arch wire placement.
With a minimum gap of 8 hours between doses, remaining doses will be taken as per need for the relief of pain with the total daily dose not surpassing 1200 mg.
|
|
Sperimentale: Chewing Gum Intervention
Instructions to chew sugar-free gum for a period of 10 minutes immediately post arch wire placement will be provided to the chewing gum group, 8 hourly, for pain relief.
|
Instructions to chew sugar-free gum for a period of 10 minutes immediately post arch wire placement will be provided to the chewing gum group, 8 hourly, for pain relief.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Post-archwire orthodontic pain
Lasso di tempo: Pain levels will be recorded using a 10-cm visual analog scale (vas) at the following intervals: • 2 hours • 6 hours • Bedtime (day 1) • 24 hours (day 2) • Day 3 • Day 7
|
Pain experienced by patients following placement of the initial orthodontic archwire, measured using the Visual Analog Scale (VAS).
|
Pain levels will be recorded using a 10-cm visual analog scale (vas) at the following intervals: • 2 hours • 6 hours • Bedtime (day 1) • 24 hours (day 2) • Day 3 • Day 7
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Rescue analgesic consumption
Lasso di tempo: Within 7 days following initial archwire placement.
|
Use of any additional analgesic medication beyond the assigned intervention.
|
Within 7 days following initial archwire placement.
|
|
Appliance-related complications
Lasso di tempo: Within 7 days following initial archwire placement.
|
Mechanical issues occurring such as bracket debonding or wire displacement.
|
Within 7 days following initial archwire placement.
|
Collaboratori e investigatori
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
- Malattie stomatognatiche
- Malattie dei denti
- Malocclusione
- Prodotti chimici organici
- Terapie
- Terapie complementari
- Modalità di terapia fisica
- Cibo
- Dieta, cibo e nutrizione
- Fenomeni fisiologici
- Cibo e bevande
- Carboidrati
- Acidi carbossilici
- Riabilitazione
- Polimeri
- Sostanze macromolecolari
- Polisaccaridi
- Prodotti biologici
- Miscele complesse
- Acidi, carbociclico
- Biopolimeri
- Fenilproponati
- Gengive vegetali
- Essudati di piante
- Caramella
- Terapia, tessuto molle
- Manipolazioni muscoloscheletriche
- Ibuprofene
- Gomma da masticare
- ACUPRESSURA
Altri numeri di identificazione dello studio
- BUHS-IRB#264/26
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .